Syngene has completed a payment of Rs. 158.2 crores on December 22, 2023 in addition to the initial payment of Rs. 395 crores made on December 1, 2023
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
Lacosamide is indicated to treat partial-onset seizures
The product will be manufactured at Lupin's Pithampur facility in India
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Subscribe To Our Newsletter & Stay Updated
